{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:27:59Z","timestamp":1792481279302,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["5274"],"award-info":[{"award-number":["5274"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajg.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:16:42Z","timestamp":1751959002000},"page":"292-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Methotrexate induced liver fibrosis is over estimated as assessed by transient elastography, acoustic radiation force impulse and serum markers"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-2204","authenticated-orcid":false,"given":"Hedy A.","family":"Badary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar K.","family":"Darweesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Darweesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-0020","authenticated-orcid":false,"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajg.2025.06.001_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajg.2025.06.001_b0010","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1155\/2017\/9632846","article-title":"Protective effects of methotrexate against proatherosclerotic cytokines: a review of the evidence","volume":"2017","author":"Mangoni","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ajg.2025.06.001_b0015","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/art.1780371013","article-title":"Methotrexate in rheumatoid arthritis: a five-year prospective multicenter trial","volume":"37","author":"Weinblatt","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ajg.2025.06.001_b0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/art.1780380904","article-title":"Light and electron micro- scopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Follow up over long treatment intervals and correlation with clinical and laboratory variables","volume":"38","author":"Kremer","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ajg.2025.06.001_b0025","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.1780380814","article-title":"Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients","volume":"38","author":"Erickson","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ajg.2025.06.001_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00044011-200626020-00001","article-title":"Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis","volume":"26","author":"Tilling","year":"2006","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.ajg.2025.06.001_b0035","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1365-2036.2006.02929.x","article-title":"Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn\u2019s disease patients treated with methotrexate","volume":"23","author":"Laharie","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2025.06.001_b0040","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/art.11015","article-title":"The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year follow-up study","volume":"48","author":"Kalden","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2025.06.001_b0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/ard.2008.099861","article-title":"Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis","volume":"68","author":"Katchamart","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ajg.2025.06.001_b0050","first-page":"3112","article-title":"Fisetin ameliorates methotrexate-induced liver fibrosis","volume":"28","author":"Kayal\u0131","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1\u20132","key":"10.1016\/j.ajg.2025.06.001_b0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-013-1830-4","article-title":"Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis","volume":"385","author":"Ali","year":"2014","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.ajg.2025.06.001_b0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00210-020-01991-2","article-title":"Protective effects of apigenin on altered lipid peroxidation, inflammation, and antioxidant factors in methotrexate-induced hepatotoxicity","volume":"394","author":"Goudarzi","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.ajg.2025.06.001_b0065","doi-asserted-by":"crossref","DOI":"10.1590\/acb370507","article-title":"Antifibrotic preventive effect of polyethylene glycol (PEG) 3350 in methotrexateinduced hepatoxicity model","volume":"37","author":"Acar","year":"2022","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.ajg.2025.06.001_b0070","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2025.06.001_b0075","doi-asserted-by":"crossref","unstructured":"Laharie, D., Zerbib, F., Adhoute, X., Boue-Lahorgue, X. (2006). Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. First published: 12 May.","DOI":"10.1111\/j.1365-2036.2006.02929.x"},{"key":"10.1016\/j.ajg.2025.06.001_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19090","article-title":"Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation","volume":"19","author":"Crossan","year":"2015","journal-title":"Health Technol Assess"},{"issue":"4","key":"10.1016\/j.ajg.2025.06.001_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.ELX.0000454686.81811.1a","article-title":"Comparison between transient elastography (Fibroscan) and liver biopsy for the diagnosis of hepatic fibrosis in chronic hepatitis C genotype","volume":"4","author":"Shiha","year":"2014","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.ajg.2025.06.001_b0090","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jmri.25550","article-title":"Liver fibrosis: Review of current imaging and MRI quantification techniques","volume":"45","author":"Petitclerc","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.ajg.2025.06.001_b0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2005.06.036","article-title":"Folate supplementation during methotrexate therapy for patients with psoriasis","volume":"53","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0100","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.scitotenv.2018.05.075","article-title":"Occurrence of PBDEs in surface sediments of metropolitan rivers: sources, distribution pattern, and risk assessment","volume":"637","author":"Cheng","year":"2018","journal-title":"Sci Total Environ"},{"issue":"518","key":"10.1016\/j.ajg.2025.06.001_b0105","first-page":"526","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2025.06.001_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","author":"Castera","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jtcvs.2007.09.039","article-title":"Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers","volume":"135","author":"Friedrich-Rust","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ajg.2025.06.001_b0120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/1529-0131(200002)43:2<464::AID-ANR30>3.0.CO;2-U","article-title":"The changing face of rheumatoid arthritis therapy: results of serial surveys","volume":"43","author":"Mikuls","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2025.06.001_b0125","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mate-Jimenez","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/1529-0131(200008)13:4<213::AID-ANR6>3.0.CO;2-2","article-title":"Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy","volume":"13","author":"Griffiths","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ajg.2025.06.001_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/keh512","article-title":"The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions","volume":"44","author":"Kinder","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajg.2025.06.001_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.clirex.2020.100003","article-title":"A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy","author":"Cervoni","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"10.1016\/j.ajg.2025.06.001_b0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14740338.2013.798299","article-title":"Safety evaluation of leflunomide in rheumatoid arthritis","volume":"12","author":"Keen","year":"2013","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.ajg.2025.06.001_b0155","first-page":"133","article-title":"Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis","volume":"15","author":"Alfaro-Lara","year":"2019","journal-title":"Reumatologiaclinica"},{"key":"10.1016\/j.ajg.2025.06.001_b0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case\u2010based presentations and evidence\u2010based conclusions","volume":"65","author":"American Academy of Dermatology Work G","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/1756-185X.13442","article-title":"Association between cumulative methotrexate dose, non\u2010invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate","volume":"22","author":"Lertnawapan","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ajg.2025.06.001_b0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0002-9343(88)80019-6","article-title":"Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis","volume":"85","author":"Shergy","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ajg.2025.06.001_b0180","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/j.1572-0241.2000.03287.x","article-title":"Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease","volume":"95","author":"Te","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajg.2025.06.001_b0185","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0190","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/ken158","article-title":"Psoriatic arthritis, methotrexate and the liver\u2013are rheumatologists putting their patients at risk?","volume":"47","author":"Lindsay","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajg.2025.06.001_b0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.dld.2011.08.013","article-title":"Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis","volume":"44","author":"Arena","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajg.2025.06.001_b0200","first-page":"459","article-title":"Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis","volume":"23","author":"Kremer","year":"1996","journal-title":"J Rheumatol"},{"issue":"46","key":"10.1016\/j.ajg.2025.06.001_b0205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis: 2002 update","volume":"2002","author":"American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2025.06.001_b0210","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ajg.2025.06.001_b0215","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/rheumatology\/kep176","article-title":"Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate","volume":"48","author":"Amital","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ajg.2025.06.001_b0220","first-page":"104","article-title":"Methotrexate hepatotoxicity in patients with rheumatoid arthritis","volume":"2","author":"Sotoudehmanesh","year":"2010","journal-title":"Middle East J Digest Dis"},{"key":"10.1016\/j.ajg.2025.06.001_b0225","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jbspin.2010.02.024","article-title":"Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate","volume":"77","author":"Park","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ajg.2025.06.001_b0230","first-page":"1029","article-title":"Prevalence and risk factors for liver fibrosis detected by transient elastography or shear wave elastography in inflammatory arthritis: a systematic review","volume":"35","author":"Rouhi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0235","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1478-3231.2007.01489.x","article-title":"Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis","volume":"27","author":"Berends","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.ajg.2025.06.001_b0240","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2133.2011.10657.x","article-title":"Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy","volume":"166","author":"Bray","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0245","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-3083.2012.04643.x","article-title":"Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers","volume":"27","author":"Chladek","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ajg.2025.06.001_b0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00403-017-1733-4","article-title":"Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study","volume":"309","author":"Rongngern","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ajg.2025.06.001_b0255","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2340\/00015555-2677","article-title":"Transient elastography may improve detection of liver fibrosis in psoriasis patients treated with methotrexate","volume":"97","author":"Talme","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajg.2025.06.001_b0260","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamadermatol.2013.9336","article-title":"The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis","volume":"150","author":"Lynch","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/00365521.2011.647412","article-title":"Evaluation of liver fibrosis by transient elastography (Fibroscan[R]) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial","volume":"47","author":"Barbero-Villares","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ajg.2025.06.001_b0270","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/MEG.0b013e3283556db5","article-title":"Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience","volume":"24","author":"Gonzalez-Lama","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0275","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","article-title":"Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case control study","volume":"53","author":"Laharie","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0280","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","volume":"19","author":"Aithal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2025.06.001_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4075","article-title":"Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate","volume":"14","author":"Lee","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.ajg.2025.06.001_b0290","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/14397595.2018.1542962","article-title":"Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate","volume":"29","author":"Miyata","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0295","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1007\/s10067-021-05678-8","article-title":"Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis","volume":"40","author":"Bafna","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0300","article-title":"Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of FibroScan and biochemical markers in routine clinical practice","author":"de Diego-Sola","year":"2023","journal-title":"Reumatolog\u00eda Cl\u00ednica"},{"key":"10.1016\/j.ajg.2025.06.001_b0305","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-021-05059-z","article-title":"Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis","volume":"42","author":"Frankowski","year":"2022","journal-title":"RheumatolInt"},{"key":"10.1016\/j.ajg.2025.06.001_b0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejim.2019.08.022","article-title":"Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography","volume":"69","author":"Erre","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.ajg.2025.06.001_b0315","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2025.06.001_b0320","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6548715","article-title":"Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study","volume":"2018","author":"Erre","year":"2018","journal-title":"Mediators Inflamm"},{"issue":"7","key":"10.1016\/j.ajg.2025.06.001_b0325","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00296-018-4039-8","article-title":"Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis","volume":"38","author":"Erre","year":"2018","journal-title":"Rheumatol Int"},{"issue":"1_suppl","key":"10.1016\/j.ajg.2025.06.001_b0330","doi-asserted-by":"crossref","DOI":"10.1177\/0300060515593255","article-title":"Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: a case\u2013control study","volume":"44","author":"Erre","year":"2016","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ajg.2025.06.001_b0335","doi-asserted-by":"crossref","unstructured":"AISF position paper on nonalcoholic fatty liver disease (NAFLD). Updates and future directions. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver 2017 May;49(5):471\u201383.","DOI":"10.1016\/j.dld.2017.01.147"},{"key":"10.1016\/j.ajg.2025.06.001_b0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0190-9622(88)80237-8","article-title":"Methotrexate in psoriasis: revised guidelines","volume":"19","author":"Roenigk","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0345","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jhep.2011.10.017","article-title":"Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R)","volume":"56","author":"de Ledinghen","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2025.06.001_b0350","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ajg.2025.06.001_b0355","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ajg.2025.06.001_b0360","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ajg.2025.06.001_b0365","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jfma.2020.08.019","article-title":"The non-invasive assessment of hepatic fibrosis","volume":"120","author":"Gheorghe","year":"2021","journal-title":"J Formosan Med Assoc = Taiwan yi zhi"},{"issue":"2","key":"10.1016\/j.ajg.2025.06.001_b0370","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","article-title":"AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2025.06.001_b0375","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver, Clinical Practice Guideline Panel, Chair: EASL Governing Board representative: & Panel members","year":"2021","journal-title":"J Hepatol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T19:46:48Z","timestamp":1753472808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197925000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1687197925000851"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2025.06.001","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate induced liver fibrosis is over estimated as assessed by transient elastography, acoustic radiation force impulse and serum markers","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}